Meeting Banner
Abstract #2552

­­­Expanding the limits of cardiovascular MR: amyloid detection in the liver and spleen

Michele Boldrini1,2, Andrea Baggiano1, Ana Martinez-Naharro1, Tushar Kotecha1, Tamer Rezk3, Daniel Knight1, James Moon4, Peter Kellman5, Julian Gillmore3, Philip Hawkins3, and Marianna Fontana1

1CMR department, National Amyloidosis Center, UCL Royal Free Hospital, London, United Kingdom, 2Internal Medicine, Università degli Studi di Pavia, Pavia, Italy, 3National Amyloidosis Center, UCL Royal Free Hospital, London, United Kingdom, 4Barts Health - Barts Heart Centre, London, United Kingdom, 5National Institute of Health, Washington, MD, United States

In this study we evaluated the utility of bolus-only ECV maps in extra-cardiac AL amyloidosis by comparing it with SAP scintigraphy findings in liver and spleen. These two techniques where performed in a large prospective cohort of patients with suspected systemic AL amyloidosis and where compared in terms of (1) diagnostic accuracy in liver and spleen amiloidosis; (2) quantification of the liver and spleen amyloid deposits. This was done using a standard acquisition for cardiac studies, with no extra image acquisition or optimization for hypochondriac regions.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords